Nectar Lifesciences (LUX:NECLF) Long-Term Debt : $16.9 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Nectar Lifesciences Long-Term Debt?

Nectar Lifesciences's Long-Term Debt for the quarter that ended in Mar. 2024 was $16.9 Mil.

Nectar Lifesciences's quarterly Long-Term Debt declined from Sep. 2023 ($22.1 Mil) to Dec. 2023 ($0.0 Mil) but then increased from Dec. 2023 ($0.0 Mil) to Mar. 2024 ($16.9 Mil).

Nectar Lifesciences's annual Long-Term Debt declined from Mar. 2022 ($38.2 Mil) to Mar. 2023 ($27.5 Mil) and declined from Mar. 2023 ($27.5 Mil) to Mar. 2024 ($16.9 Mil).

Nectar Lifesciences Long-Term Debt Historical Data

The historical data trend for Nectar Lifesciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nectar Lifesciences Long-Term Debt Chart

Nectar Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

16.30

17.61

38.20

27.53

16.90

Nectar Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															27.53	-	22.07	-	16.90

Nectar Lifesciences (LUX:NECLF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nectar Lifesciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nectar Lifesciences (LUX:NECLF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (LUX:NECLF) » Definitions » Long-Term Debt

Traded in Other Exchanges

NECLIFE:India 532649:India

Address

SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009

Website

https://www.neclife.com

Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (LUX:NECLF) Headlines

No Headlines